Immune cell diversity contributes to the pathogenesis of myocarditis

Heart Fail Rev. 2019 Nov;24(6):1019-1030. doi: 10.1007/s10741-019-09799-w.

Abstract

Myocarditis (MCD) is a type of inflammatory disease in which inflammatory cells infiltrate the myocardium, leading to cardiac dysfunction, myocardial necrosis, and fibrosis. Although it has been reported that MCD is mediated by T cells, the immune system is complex and includes many types of immune cells that interact with one another. Through investigations of the inflammatory responses in MCD including myocardial necrosis, fibrosis, and arrhythmia, we have gained further insight into the pathogenesis of MCD. This article aims to discuss the diversity and the roles of immune cells involved in the pathogenesis of MCD. Moreover, immunotherapy for the treatment of MCD remains controversial, and further investigation is required to identify accurate immunotherapies for special cell types.

Keywords: Immune cell diversity; Immunotherapy; Interaction; Myocarditis; Pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity / immunology
  • Animals
  • B-Lymphocytes / immunology
  • Female
  • Fibrosis
  • Histocompatibility Antigens Class II / immunology
  • Humans
  • Immune System / cytology
  • Immune System / physiology*
  • Immunotherapy / methods
  • Killer Cells, Natural / immunology
  • Macrophages / immunology
  • Male
  • Mice
  • Models, Animal
  • Myocarditis / immunology*
  • Myocarditis / physiopathology
  • Myocarditis / therapy
  • Myocardium / immunology*
  • Myocardium / pathology
  • Receptors, CCR2 / metabolism
  • T-Lymphocytes, Regulatory / immunology
  • Ventricular Remodeling / immunology

Substances

  • Histocompatibility Antigens Class II
  • Receptors, CCR2